GLP-1 RAs are considered one of the most promising drugs for repurposing as a treatment for dementia.87 We found the most robust evidence for reducing dementia risk with both RCTs and observational studies finding them protective, including those adjusting for duration of diabetes. This evidence concerns the gene GLP1R and diabetes mellitus.